Mirae Asset Global Investments said it is waiting for Anbang Insurance's official explanation of why it had not fulfilled all the requirements needed to close a $5.8 billion hotel deal.
A letter has been sent to Anbang Insurance urging it to respond within 15 days with a further notification that unless it replies by May 2, Mirae Asset may terminate the deal.
Anbang Insurance, the seller of the hotel, claimed that Mirae Asset, the preferred bidder, had reneged on its obligations to closing the deal on April 17.
But Mirae Asset said that this was due to an ongoing legal dispute between the Anbang Insurance and a third party, which it uncovered while conducting due diligence on the deal.
"We've kept requesting explanatory materials on it from the Anbang unit, but it hasn't responded yet," Mirae Asset said.
According to a Bloomberg report, Anbang Insurance sought an order filed with a Delaware court in the US compelling Mirae Asset to fulfill its obligations under the purchase agreement.
The said contract was for Mirae Asset Financial Group to purchase 15 five-star hotels and resorts in the United States from Anbang, which the latter had acquired from Blackstone in 2016.
The list of hotels includes JW Marriott Essex House New York, The Ritz-Carlton Half Moon Bay, Four Seasons Silicon Valley, Four Seasons Arizona, Four Seasons Resort and Residences Jackson Hole, Hotel Fairmont Scottsdale Princess, InterContinental Miami, Montage Laguna Beach, InterContinental Chicago, and The Westin St. Francis San Francisco.
Mirae Asset had paid a 10 percent deposit in September.
To finance the acquisition, Mirae Asset Financial Group will raise $1.8 billion through its affiliates, Mirae Asset Daewoo, and Mirae Asset Global Investments. The remaining $40 billion will be sourced through a partnership with US investment bank Goldman Sachs.
Due to the COVID-19 outbreak, the parties have also continuously discussed delaying the deal's closing date and rearranging other conditions.


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Instagram Outage Disrupts Thousands of U.S. Users
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



